C31H33N3O6S
575.7 g/mol
API
Zafirlukast
CAS107753-78-6
Category
API
Compound Class
Amide
Primary Use
Pharmaceutical Raw Material
Zafirlukast is an orally administered leukotriene receptor antagonist (LTRA) used in the chronic management of asthma. It is generally well tolerated, but potential side effects include headache, stomach upset, and rare but serious risks such as liver failure.
leukotriene receptor antagonistasthma management
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 107753-78-6
Related Compounds
Safety Reference
H413May cause long lasting harmful effects to aquatic life
Identifiers
IUPAC Name
cyclopentyl N-[3-[[2-methoxy-4-[(2-methylphenyl)sulfonylcarbamoyl]phenyl]methyl]-1-methylindol-5-yl]carbamate
InChIKey
YEEZWCHGZNKEEK-UHFFFAOYSA-N
SMILES
CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC
Synonyms (34)
- ZLK
- Zafirlukast (JAN/USAN/INN)
- Accolate
- Accolate (TN)
- Accoleit
- Aeronix
- IC I-2204219
- ICI 204,219
- Olmoran
- Respix
- Vanticon
- ZAFIRLUKAST [MART.]
- Zafirlukast (Standard)
- Zafirlukast(Accolate)
- Zafirlukast, >=98% (HPLC)
- Zafirst
- zafirlukast
- zafirlukastum